Cannabis User

2

Review clinical trials related to Cannabis User. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Effect of Acute Exercise on Cognitive Functions and Blood Markers of Brain Plasticity in Regular Chronic Cannabis Users

The endocannabinoid system (ECS) is a complex endogenous signaling system made up of transmembrane cannabinoid receptors (CB1 and CB2 receptors), their endogenous lipid-derived ligands (the endocannabinoids - eCBs), and enzymes for ligand biosynthesis and degradation. Interestingly, exercise increase plasma AEA, one of the most famous endocannabinoid. This increase could be involved in exercise-induced neurogenesis and other beneficial exercise adaptations. Chronic cannabis use is associated with alteration of ECS activity. The aim of the study is to compare ECS response to exercise between chronic cannabis users and non-users.

Participants needed: 60
Trial details
Age: 18-35Biological sex: AllType: InterventionalSponsor: University Hospital, LilleUpdated: May 15, 2026Locations: 1
Eligibility criteria

Cannabis consumption > 100 times in lifetime, last exposure < 7 days, and recent... [+5]

Disorders of use of other substances (alcohol, cocaine, opioid, or synthetic dru... [+6]

Status: Recruiting

Online Brief Advice Intervention for Heavy Cannabis Users

This project will evaluate whether a brief online intervention focused on cannabis withdrawal can increase awareness and insight about cannabis use disorder among daily cannabis users. The study will employ a randomised controlled trial design comparing an intervention consisting of a short educational video on cannabis withdrawal and personalised feedback on the Cannabis Withdrawal Scale, against a control condition of a relaxation video and mood questionnaire. The investigators will aim to recruit at least 100 daily cannabis users (minimum 25 days of cannabis use /month and minimum 3.5g cannabis/week \[low-medium daily use\]) through Prolific, an online research participant platform. Potential participants will complete a brief screening questionnaire (1 minute) to confirm that participants meet inclusion criteria, before randomisation. The experiment will last 10-15 minutes and will include baseline demographic and substance use measures, the intervention or control condition, and outcome measures. The primary outcome will be cannabis use awareness and insight as measured by the Substance Use Awareness and Insight Scale (SAS). Secondary outcomes will include intention to change cannabis use. This study aims to determine whether a short online intervention can increase awareness about cannabis withdrawal among heavy users. If successful, subsequent studies will be designed to assess these outcomes over the longer-term.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: King's College LondonUpdated: Jan 30, 2026Locations: 1
Eligibility criteria

Adults (>18 years) [+2]

Participant is prescribed medical cannabis by a healthcare professional